The value of quantitative patient preferences in regulatory benefit-risk assessment

Mart oude Egbrink, Maarten IJzerman*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

34 Citations (Scopus)
6 Downloads (Pure)


Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.

Original languageEnglish
Article number22761
JournalJournal of Market Access and Health Policy
Issue number1
Early online date1 Apr 2014
Publication statusPublished - 2014
Externally publishedYes

Bibliographical note

Funding Information:
This article has been partly supported by an educational grant from Université Claude Bernard Lyon I, France.

Publisher Copyright:
© 2014 Mart oude Egbrink and Maarten IJzerman.


Dive into the research topics of 'The value of quantitative patient preferences in regulatory benefit-risk assessment'. Together they form a unique fingerprint.

Cite this